Investigational Drug Targets Sleep Apnea and Nocturnal Hypertension
A phase 2 trial will evaluate the drug’s potential to reduce upper airway obstruction and nocturnal hypertension in patients with moderate-to-severe OSA.
Tag: sleep apnea
Must-Read Insights
Staff's Top Picks
Sleep Apnea Patients’ Heart Health Improves with Continuous CPAP Use
Research from the European Respiratory Society International Congress indicates that using a CPAP machine at night can lower cardiovascular disease mortality in OSA patients and may be more effective than weight loss drugs in reducing arterial plaque build-up.